Order Article Reprints

Lee PY, Oen KQX, Lim GRS, Hartono JL, Muthiah M, Huang DQ, Teo FSW, Li AY, Mak A, Chandran NS, et al. Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study. Cancers. 2021; 13(6):1308. https://doi.org/10.3390/cancers13061308

Lee, Pei Yi, Kellynn Qi Xuan Oen, Grace Rui Si Lim, Juanda Leo Hartono, Mark Muthiah, Daniel Q. Huang, Felicia Su Wei Teo, Andrew Yunkai Li, Anselm Mak, Nisha Suyien Chandran, and et al. 2021. "Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study" Cancers 13, no. 6: 1308. https://doi.org/10.3390/cancers13061308

Lee, P. Y., Oen, K. Q. X., Lim, G. R. S., Hartono, J. L., Muthiah, M., Huang, D. Q., Teo, F. S. W., Li, A. Y., Mak, A., Chandran, N. S., Tan, C. L., Yang, P., Tai, E. S., Ng, K. W. P., Vijayan, J., Chan, Y. C., Tan, L. L., Lee, M. B.-H., Chua, H. R., ... Tay, S. H. (2021). Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study. Cancers, 13(6), 1308. https://doi.org/10.3390/cancers13061308